Defunct Company
Total Trials
8
As Lead Sponsor
6
As Collaborator
2
Total Enrollment
542
NCT02005731
Low Intensity Extracorporeal Shockwave Therapy for Patients With Erectile Dysfunction
Phase: N/A
Role: Lead Sponsor
Start: Nov 30, 2012
Completion: Nov 30, 2013
NCT01814852
Low Intensity Extracorporeal Shockwave Therapy (LI-ESWT) by 'Renova' for Patients With Erectile Dysfunction
Start: Dec 31, 2012
Completion: Feb 28, 2015
NCT01811797
Safety and Efficacy Associated With Treating Erectile Dysfunction Patients With Low Intensity Shockwaves by Renova
Start: Oct 31, 2013
Completion: Jun 30, 2014
NCT02152683
Linear Focused Shockwave Treatment for Erectile Dysfunction
Start: Mar 31, 2014
Completion: Aug 31, 2015
NCT02906852
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Start: Aug 1, 2016
Completion: Dec 31, 2018
NCT03116633
Concordance of Inivata Liquid Biopsy With Standard Tissue Biopsy
Start: Jun 30, 2017
NCT04166487
Plasma-Adapted First-Line Pembro In NSCLC
Phase: Phase 2
Role: Collaborator
Start: Jan 13, 2020
Completion: Dec 1, 2025
NCT05116618
Detection of Resistance Mechanisms in Cerebrospinal Fluid for EGFR-mutant, ALK- and ROS1-rearranged
Start: Jan 6, 2022
Completion: Sep 15, 2022